David Karp’s wallet just got a lot fatter.
After a flurry of speculation over the weekend, Tumblr in New York is being acquired by Sunnyvale, CA-based Yahoo, in a deal announced early Monday at the previously reported price of $1.1 billion,... Read more »
I’m on the phone with Andy Miller, and I don’t know where to begin.
Ask him about working with Steve Jobs at Apple? About how Leap Motion may or may not be the next Apple? Or what about how that $348... Read more »
We’ve all been there, standing in a superstore, shopping list in hand. We stare at the dozens and dozens of rows of consumer products before us and don’t have a clue where to find anything.
But if you’re in China, Appconomy... Read more »
When Astellas Pharma shuttered the labs of OSI Pharmaceuticals last week, no one felt that loss as acutely as the residents of Long Island, NY. OSI, famed for its lung cancer drug erlotinib (Tarceva), had shown that it was possible to... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
A smattering of fundraising announcements involving Boston-area companies and investors, along with a student entrepreneurship program in this collection of local news tidbits:
—Skyword, a Boston-based marketing company that links freelance copywriters with advertisers and other clients, has raised... Read more »
For cities to truly thrive in this economy, fresh ideas must be cross-pollinated from beyond their borders—and New York offers its share of honey to lure in startups. This international gateway can be the place for companies to break into the... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
Few could accuse XBiotech CEO John Simard of failing to think big.
The Austin, TX-based startup he founded in 2005 is testing a novel biological drug candidate that is aiming to treat the persistent inflammation that makes cancer patients feel so... Read more »